Columbia & Cornell Gastroenterology & Hepatology - 38th Annual



Learning Objectives:

  • Describe new pharmacotherapy of IBD and enhanced surgical treatments
  • Improve the ability to monitor, optimize and personalize the dosing of anti-TNF agents
  • Gain insight and understanding of the role and appropriate use of use anti-integrin therapy
  • Describe the safety profile of various therapeutics in treating IBD in the pregnancy
  • Discuss the role of new therapies for hepatitis B, hepatitis C, and hepatocellular carcinoma
  • Describe treatment of C. difficile colitis
  • Recognize the utility of pharmacologic and endoscopic therapies for reflux disease and Barrett’s esophagus
  • Gain insight on the endoscopic management of esophageal cancer
  • Describe the role of endoscopic mucosal dissection and STER for early GI malignancies
  • Determine appropriate candidates for ablation of Barrett’s esophagus
  • Understand the role of new endoscopic techniques such as POEM for treating achalasia
  • Describe the role of therapeutic endoscopic ultrasound in clinical practice
  • Understand the potential role for probiotics in the management of gastrointestinal disorders
  • Learn novel endoscopic techniques for complicated hepatobiliary diseases/pancreatitis
  • Recognize the utility of endoscopic techniques for managing pancreatic fluid collections
  • Describe the current treatment options for chronic pancreatitis
  • Improve understanding of how to evaluate and treat patients with upper gastrointestinal motility and functional bowel disorders
  • Learn optimal dosing strategies for colonoscopy bowel preparation
Format: Succinct presentations and extensive discussion with audience participation, luncheon session with in-depth discussions with faculty on topics of participants choice.


December 3, 2021


Virtual Conference